Sangamo BioSciences | SGMO - DEUDA





DEUDA Cambio Fecha
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 57.32B 2.72B 2026-03
Bayer EUR 36.45B 2.93B 2025-12
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 8.09B 1.53B 2026-06
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cipla INR 6.14B 1.76B 2026-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.93M 14K 2026-03
CSL USD 11.96B 219M 2024-12
Gilead Sciences USD 22.17B 2.76B 2026-03
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
J&J USD 54.99B 7.05B 2026-03
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Merck USD 49.12B 222M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Omeros USD 442.16M 199K 2023-09
Pfizer USD 63.19B 536M 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 1.04B 3.08M 2026-03
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06